ArticleBMC microbiology2025
A new member of the novel, non-core Brucella clade: An exotic frog isolate closely related to atypical Brucella isolates from recent human brucellosis cases in Australia.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- First report of aFrontiers in veterinary science · 2026Article
- Advancing the study of microbial symbionts of amphibians and reptiles.Frontiers in amphibian and reptile science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOver the past few decades, the Brucella genus has seen a significant increase in novel strains that deviate from classical Brucella spp. due to their atypical phenotypes. B. inopinata, an atypical Brucella species first isolated from a patient, was recently found in a White's tree frog, raising the question of whether amphibians are reservoirs for these emerging human pathogens. Unfortunately, monitoring atypical Brucella remains challenging because misidentification with Ochrobactrum spp. and Brucella melitensis is common when using routine microbiological tests.
resultsIn our study, we describe a Brucella strain isolated from White's tree frogs (Litoria caerulea) that were initially examined for chytridiomycosis after they had developed dermal abnormalities. Classical microbiological and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analyses and a species-specific polymerase chain reaction confirmed that isolate CVUAS_1139.3 is an atypical Brucella strain. This non-fastidious, fast growing, flagellated, and motile bacterium is not susceptible to lysis by the Brucella phages used for typing. Further characterization using the differential metabolic phenotyping approach, revealed that Brucella sp. CVUAS_1139.3 could be differentiated from classical Brucella spp., as well as from Ochrobactrum anthropi and O. intermedium, based on its metabolic activity. The substrate utilization patterns may be suitable for a simple and cost-effective diagnostic assay. Phylogenetic analysis positioned Brucella sp. CVUAS_1139.3 distant from the classical Brucella spp. within the novel, non-core Brucella clade. Within this clade, Brucella sp. CVUAS_1139.3 shares a close phylogenetic relationship with B. inopinata strains and various African bullfrog isolates, and it is most closely related to a recently identified human isolate from Australia. Antimicrobial resistance testing revealed that it is susceptible to antibiotics widely applied in standard treatment regimens. In human THP-1 macrophage-like cells, the replication rate of the novel Brucella frog isolate was comparable to that of B. inopinata.
conclusionIn summary, the amphibian-derived strain Brucella sp. CVUAS_1139.3 clusters phylogenetically with and is phenotypically alike to previously reported isolates from amphibian hosts and human brucellosis patients within the novel, non-core clade. Our report and other studies suggest that exotic frogs are potential reservoirs for human pathogenic Brucella spp., which might pose an underestimated zoonotic hazard for exposed individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.